2026-525752-29-00已完成4 期
A Phase I, open-label study in healthy adults comparing the availability in the body of the active substance lidocaine following administration of 2% and 4% lidocaine gel into the urethra
Farco-Pharma GmbH1 个研究点 分布在 1 个国家目标入组 28 人开始时间: 2026年6月1日最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 28
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 性别
- Male
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Dr. Jennifer Vollmer
Scientific
Farco-Pharma GmbH
研究点 (1)
Loading locations...
相似试验
已完成
1 期
A Study of How Ibuzatrelvir is Taken up Into the Blood of Healthy Adults After Taking Different Tablets of IbuzatrelvirCoronavirus Disease 2019Coronavirus Disease 2019 (COVID-19)COVID-19 (Coronavirus Disease 2019)Upper Respiratory Tract InfectionsRespiratory Tract DiseasesCOVID-19 InfectionCOVID-19 SARS-CoV-2 InfectionLung DiseasesCOVID-19Respiratory Tract InfectionPneumoniaNCT07552779Pfizer17
进行中（未招募）
1 期
An open-label, phase I multicenter, clinical trial of NECVAX-NEO1 in addition to anti-PD-1 or anti-PD-L1 monoclonal antibody checkpoint inhibitor monotherapy in patients with solid tumors2024-513716-95-00Nec Oncoimmunity AS6
已完成
1 期
An open-label, single-dose phase 1 study to evaluate the Absorption, Metabolism, and Excretion of [14C]-AZ-3102 in Healthy Male Subjects2023-504916-14-00Azafaros B.V.7
已完成
1 期
A Phase I, open-label, non-randomized study to assess the absorption, distribution, metabolism and excretion (ADME) and pharmacokinetics of LTP001 following a single oral dose of [14C]LTP001 in healthy male participants2025-524172-29-00Novartis Pharma AG6
终止
1 期
Phase I Study of [111In]-FPI-2107 in EGFR Mutation-positive NSCLCEGFR Mutation-positive NSCLCNCT07500987AstraZeneca6